PipelinePharma Logo

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Artemether manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

artemether

Injection 40 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20847

This CTD dossier owner and manufacturer is a GMP & GLP certified manufacturer of cosmetics and pharmaceuticals with a 29-year production history. They specialize in non-beta lactum injections, including Artesunate, Artemether, Alpha Beta Arteether, Citicolin, Dexamethasone Sodium Phosphate, Diclofenac, Dipyrone, Glutathione, Hydrocortisone Sodium Succinate, Hyoscine Butyl Bromide, Iron Sucrose, Lidocaine, Magnesium Sulphate, Nefopam Hydrochloride, Omeprazole, Pantoprazole, Paraldehyde, Tranexamic Acid, Triamcinolone Acetonide, and Vancomycin. They also produce ear, eye, and nasal drops, as well as external applications, though these products are currently manufactured in a facility not yet holding WHO GMP approval. Their cosmetics line includes moisturizing creams & lotions, anti-aging creams, face washes, sunscreens, under eye creams, shampoos & conditioners, hair growth serums, skin brightening serums & creams, depigmentation creams, acne prevention products, stretch mark prevention creams, and intimate washes. They operate facilities in the EU and North America, serving a global clientele.

artemether

Oral suspension 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401
This pharmaceutical company has two decades of experience manufacturing cost-effective medications across various therapeutic areas. Their product portfolio includes tablets, capsules, injectables, liquid orals, and topical solutions. They specialize in expert formulation development and possess advanced analytical capabilities to ensure quality and regulatory compliance. The company's key markets include the EU and North America. Their GMP certified manufacturing facility is strategically located near a major commercial hub.

Manufacturer usually replies in 21 days

artemether

Injection 20 mg, 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401
This pharmaceutical company has two decades of experience manufacturing cost-effective medications across various therapeutic areas. Their product portfolio includes tablets, capsules, injectables, liquid orals, and topical solutions. They specialize in expert formulation development and possess advanced analytical capabilities to ensure quality and regulatory compliance. The company's key markets include the EU and North America. Their GMP certified manufacturing facility is strategically located near a major commercial hub.

Manufacturer usually replies in 21 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Artemether is a medication used to treat malaria. Although manufacturers of artemether produce drugs with it as the standalone ingredient, it is almost always marketed in combination with lumefantrine. Artemether suppliers market it in the form of oral tablets as well as injectable solutions. The developer and earliest manufacturer of artemether/lumefantrine medications is Novartis, who markets it under the trade name Coartem. The standalone formulation was first introduced into medical use in 1987, whereas the artemether/lumefantrine combination formulation was first approved in 1992. Both drugs have since gained approvals in over 80 countries worldwide, including the U.S., China, numerous African countries and across Europe. What is more, the drug has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Alternatives to artemether are other artemisinin class malaria drugs such as dihydroartemisinin and artesunate. The prices of artemether medications are not particularly high. Its wholesale cost in the developing world typically falls into a range of 0,10 EUR to 1,00 EUR per daily treatment dose.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.